Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cálculo
10
Funciones de varias variables complejas
4
Historia
4
Matemáticas
4
Personas con discapacidades
4
Análisis matemático
3
Ciencias sociales
3
Desórdenes de la comunicación
3
Ecuaciones diferenciales parciales
3
Funciones analíticas
3
Funciones de varias variables reales
3
Métodos estadísticos
3
Seguridad alimentaria
3
Sinfonías
3
ALGORITHMS
2
ALGORITMOS
2
AUTOMATIZACION DE INDICES
2
Análisis funcional
2
Análisis multivariante
2
BASES DE DATOS
2
Bibliotecas públicas
2
Cambios climáticos
2
Cálculo de variaciones
2
DATABASES
2
Diseño experimental
2
Drama
2
Educación
2
Education
2
Enfermedades transmisibles
2
Estado
2
-
833001por Ella, Raches, Reddy, Siddarth, Blackwelder, William, Potdar, Varsha, Yadav, Pragya, Sarangi, Vamshi, Aileni, Vinay K, Kanungo, Suman, Rai, Sanjay, Reddy, Prabhakar, Verma, Savita, Singh, Chandramani, Redkar, Sagar, Mohapatra, Satyajit, Pandey, Anil, Ranganadin, Pajanivel, Gumashta, Raghavendra, Multani, Manish, Mohammad, Shameem, Bhatt, Parul, Kumari, Laxmi, Sapkal, Gajanan, Gupta, Nivedita, Abraham, Priya, Panda, Samiran, Prasad, Sai, Bhargava, Balram, Ella, Krishna, Vadrevu, Krishna Mohan“…The primary outcome was the efficacy of the BBV152 vaccine in preventing a first occurrence of laboratory-confirmed (RT-PCR-positive) symptomatic COVID-19 (any severity), occurring at least 14 days after the second dose in the per-protocol population. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833002por Sipilä, Pyry N, Heikkilä, Nelli, Lindbohm, Joni V, Hakulinen, Christian, Vahtera, Jussi, Elovainio, Marko, Suominen, Sakari, Väänänen, Ari, Koskinen, Aki, Nyberg, Solja T, Pentti, Jaana, Strandberg, Timo E, Kivimäki, Mika“…Although we found little difference in the infection-dementia association by type of infection, associations were stronger for vascular dementia than for Alzheimer's disease (aHR 2·09 [95% CI 1·59–2·75] versus aHR 1·20 [1·08–1·33] in the primary cohort and aHR 3·28 [2·65–4·04] versus aHR 1·80 [1·53–2·13] in the replication cohort). INTERPRETATION: Severe infections requiring hospital treatment are associated with long-term increased risk of dementia, including vascular dementia and Alzheimer's disease. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833003por Bernigaud, Charlotte, Bertold, Clémence, Seitz-Polski, Barbara, Cardot-Leccia, Nathalie, Passeron, Thierry, Chosidow, Olivier“…Une production d’IFN-α rapide et importante chez les patients Covid-19 est corrélée à une rapide élimination du virus et des infections peu sévères/modérées. Notre patiente ayant « contrôlé » sa COVID-19 par la production d’IFN-α, aurait pu stimuler en parallèle la formation de granulomes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833004por Blaise, Manon L., Rocher, Fanny, Spittler, Hélène, Sanchez, Adrien, Butori, Catherine, Coco, Lucia, Puma, Angela, Martel, Arnaud, Gonfrier, Géraldine, Passeron, Thierry, Montaudie, Henri“…Comme les patients atteints de cancers sont particulièrement exposés aux formes sévères/mortelles, la vaccination est recommandée. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833005por Penso, Laetitia, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud, Sbidian, Emilie“…INTRODUCTION: De nombreuses comorbidités, dont le psoriasis, ont été associées à des formes sévères de COVID-19, définies par une hospitalisation. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833006por Abdelli, Wissal, Sassi, Wiem, Alaoui, Fatima, Ben Slimane, Malek, Souissi, Asmahene, Mokni, Mourad“…La PEAG est une toxidermie sévère. Elle est due aux médicaments dans plus de 90 % des cas dont : ampicilline/amoxicilline, sulfamides, terbinafine, diltiazem. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833007por Hadjadj, J., Planas, D., Ouedrani, A., Buffier, S., Delage, L., Nguyen, Y., Bruel, T., Stolzenberg, M.C., Staropoli, I., Morbieu, C., Henriquez, S., Mouthon, L., Rieux-Laucat, F., Chatenoud, L., Schwartz, O., Terrier, B.“…Après 3 mois de suivi, 2 patients traités par rituximab présentaient une infection symptomatique peu sévère à SARS-CoV-2, 4 à 7 jours après la seconde dose de vaccin. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833008por Ward, Thomas, Glaser, Alex, Johnsen, Alexander, Xu, Feng, Hall, Ian, Pellis, Lorenzo“…Concerns around the impact on vaccine effectiveness, transmissibility and severity are now driving the public health response to these variants. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833009por Mammou Mraghni, S., Drumez, E., Aeschlimann, F., Pajot-Audouin, C., Bader-Meunier, B., Carbasse, A., Clet, J., Deslandre, C., Duquesne, A., Dusser, P., Guillaume-Czitrom, S., Hentgen, V., Koné-Paut, I., Melki, I., Quartier, P., Hachulla, E., Belot, A.“…Cette population de jeunes patients immuno-déprimés est considérée comme une population à risque de formes sévères de COVID-19. L’objectif de notre étude est d’évaluer le degré de sévérité et l’issue de l’infection à SARS-CoV-2 chez les patients atteints de RMD (avec une arthrite juvénile idiopathique, une maladie auto-inflammatoire, une vascularite ou une maladie auto-immune systémique) exposés à des traitements immuno-modulateurs, au travers d’une cohorte prospective française. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833010por Epelboin, Sylvie, Labrosse, Julie, De Mouzon, Jacques, Fauque, Patricia, Gervoise-Boyer, Marie-José, Levy, Rachel, Sermondade, Nathalie, Hesters, Laetitia, Bergère, Marianne, Devienne, Claire, Jonveaux, Philippe, Ghosn, Jade, Pessione, Fabienne“…It appears essential to be aware of this, notably in populations at known risk of developing a more severe form of infection or obstetrical morbidities and in order for obstetrical units to better inform pregnant women and provide the best care. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833011por Gohil, Shruti K, Maurice, Annabelle De St, Yokoe, Deborah S, Yokoe, Deborah S, Cohen, Stuart H, Torriani, Francesca J, Grein, Jonathan, Robinson, Philip A, Mabalot, Shannon C, Pedrani, Paula, Park, Jessica, Platt, Richard, Huang, Susan S“…BACKGROUND: COVID-19 patients can remain positive by PCR-testing for several months. Pre-admission or pre-procedure testing can identify recovered asymptomatic patients who may no longer be contagious but would require precautions according to current CDC recommendations (10 days). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833012por Dalai, Sudeb C, Dines, Jennifer N, Snyder, Thomas M, Gittelman, Rachel M, Eerkes, Tera, Vaney, Pashmi, Howard, Sally, Akers, Kipp, Skewis, Lynell, Monteforte, Anthony, Witte, Pamela R, Wolf, Cristina, Nesse, Hans, Qadeer, Jia, Duffy, Sarah, Svejnoha, Emily, Taromino, Caroline, Kagen, Michael, Kaplan, Ian M, Alsobrook, John, Manley, Thomas, Baldo, Lance“…The assay was employed in several retrospective and prospective cohorts to assess primary and secondary Positive Percent Agreement (PPA) with SARS-CoV-2 RT-PCR (N=205; N=77); primary and secondary Negative Percent Agreement (NPA; N=87; N=79); PPA compared to SARS-CoV-2 serology (N=55); and pathogen cross-reactivity (N=38). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833013por Tarbell, Evan D, Van Wart, Scott A, Shah, Dhaval K, Walker, Laura M, Santulli, Andrew, Connolly, Lynn E, Mager, Donald E, Brown, Ashley N, Ambrose, Paul G“…BACKGROUND: ADG20 is a fully human IgG1 monoclonal antibody engineered to have potent and broad neutralization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other SARS-like CoVs with pandemic potential and an extended half-life. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833014por Richard, Stephanie A, Pollett, Simon, Epsi, Nusrat J, Maves, Ryan C, Maves, Ryan C, Utz, Gregory, Lalani, Tahaniyat, Mody, Rupal, Ganesan, Anuradha, Colombo, Rhonda E, Colombo, Chris, Lindholm, David A, Lindholm, David A, Madar, Cristian, Chi, Sharon, Huprikar, Nikhil, Larson, Derek, Bazan, Samantha, Byrne, Celia, English, Caroline E, Parmelee, Edward, Mende, Katrin, Simons, Mark, Burgess, Timothy, Tribble, David, Agan, Brian“…COVID-19 illness symptom severity and duration were derived from surveys initiated in late 2020. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833015por Van Wart, Scott A, Tarbell, Evan D, Narayan, Kristin, Walker, Laura M, Connolly, Lynn E, Ambrose, Paul G“…BACKGROUND: ADG20 is a fully human IgG1 monoclonal antibody engineered to have potent and broad neutralization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other SARS-like CoVs with pandemic potential as well as an extended-half-life. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833016por Izaguirre, Natalie E, Sherman, Amy C, Crombie, Jennifer, Desjardins, Michaël, Cheng, Chi-An, Gilboa, Tal, Powell, Megan, Bausk, Bruce P, Abasciano, Noah, Baker, Peter, McDonough, Mikaela, Armand, Philippe, Walt, David, Issa, Nicolas C, Baden, Lindsey R“…BACKGROUND: Patients with lymphoid malignancies are at high risk of severe COVID-19 disease and were not included in the phase 3 mRNA vaccine trials. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833017por Grobler, Jay, Strizki, Julie, Murgolo, Nicholas, Gao, Wei, Cao, Youfang, Zhang, Ying, Du, Jiejun, Nair, Manoj, Huang, Yaoxing, Luo, Yang, Hazuda, Daria, Ho, David D, Ho, David D“…METHODS: MOV activity against several SARS-CoV-2 variants, was evaluated in an in vitro infection assay. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833018por Andrade, Viviane M, Christensen-Quick, Aaron, Agnes, Joseph, Tur, Jared, Reed, Charles C, Kalia, Richa, Marrero, Idania, Elwood, Dustin, Schultheis, Katherine, Purwar, Mansi, Reuschel, Emma, McMullan, Trevor, Pezzoli, Patrick, Kraynyak, Kimberly A, Sylvester, Albert, Mammen Jr., Mammen P, Tebas, Pablo, Kim, J Joseph, Weiner, David, Smith, Trevor R F, Ramos, Stephanie, Humeau, Laurent, Boyer, Jean, Broderick, Kate“…BACKGROUND: Global surveillance has identified emerging SARS-CoV-2 variants of concern (VOC) associated with increased transmissibility, disease severity, and resistance to neutralization by current vaccines under emergency use authorization (EUA). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833019por Ma, Qinhai, Wang, Zhoulang, Chen, Ruihan, Lei, Biao, Liu, Bin, Jiang, Haiming, Chen, Zexing, Cai, Xuejun, Guo, Xiaowen, Zhou, Meihua, Huang, Jicheng, Li, Xiaobo, Dai, Jun, Yang, Zifeng“…BACKGROUND: Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) pose a huge threat to human public health, no specific treatment is available. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
833020por Chen, Si, Xiao, Xiuman, Lin, Su, Zhu, Jianghu, Liang, Lidan, Zhu, Minli, Yang, Zuqin, Chen, Shangqin, Lin, Zhenlang, Liu, Yanli“…Cranial magnetic resonance imaging (MRI) was performed several months after birth. The neurological outcomes at 12 to 18 months of age were compared with the Gesell Developmental Schedules (GDS). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto